Skip to main content
Veterinary Medicines

Vasotop 0,625 mg Tabletten

Authorised
  • Ramipril

Product identification

Medicine name:
Vasotop 0,625 mg Tabletten
Vasotop P 0.625 mg, tablet voor honden
Active substance:
  • Ramipril
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ramipril
    0.63
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA05
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Carton box containing six 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing one 15 mL HD polyethylene container containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing three 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10303
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0245/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 25/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."